ENTEROBACTERIACEAE INFECTIONS
Clinical trials for ENTEROBACTERIACEAE INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new ENTEROBACTERIACEAE INFECTIONS trials appear
Sign up with your email to follow new studies for ENTEROBACTERIACEAE INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common antibiotic spare Last-Resort drugs for ICU lung infections?
Disease control CompletedThis study looked at whether a common antibiotic (piperacillin-tazobactam) could effectively treat ventilator-associated pneumonia in ICU patients who carry resistant bacteria in their gut. The goal was to see if this approach could reduce the need for stronger, last-resort antib…
Matched conditions: ENTEROBACTERIACEAE INFECTIONS
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Superbug outbreak in ICU during COVID: lessons learned
Knowledge-focused CompletedThis study looks back at an outbreak of a hard-to-treat bacteria (VIM-producing Enterobacter cloacae) in an intensive care unit during the 2020 COVID-19 pandemic. Researchers reviewed the cases of 14 ICU patients who had this superbug to understand how the hospital managed the ou…
Matched conditions: ENTEROBACTERIACEAE INFECTIONS
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
ICU superbug study reveals resistance patterns
Knowledge-focused CompletedThis completed study looked at 314 ICU patients with bloodstream infections caused by Enterobacterales bacteria. Researchers identified how often these bacteria were resistant to common antibiotics and what patient factors increased the risk. The goal was to understand resistance…
Matched conditions: ENTEROBACTERIACEAE INFECTIONS
Sponsor: Ankara City Hospital Bilkent • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:19 UTC